Clinical trial
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who…
NCT00233506 · University of Iowa, Other · Completed
Key facts
| NCT number | NCT00233506 |
|---|---|
| Title | A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated |
| Official title | A Dose-Finding Study of CpG 7909 in Previously Treated Chronic Lymphocytic Leukemia |
| Lead sponsor | University of Iowa, Other |
| Collaborators | Mayo Clinic Pfizer Industry National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | CpG 7909 |
| Enrollment | 41 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Oct 5, 2005 |
| Last update posted | Feb 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: